Laura A. Williams

Laura Williams

Laura A. Williams

Senior Vice President of Clinical Development

Laura A. Williams MD joined Sanifit in June 2020 as our Senior Vice President of Clinical Development.

Dr. Williams is a results-oriented, accomplished, executive leader with 20+ years of pharmaceutical drug development experience, spanning all phases and across numerous therapeutic areas (virology[HIV and HCV], cardiovascular, renal, maternal and women’s health, including infertility, etc.). She has a proven track-record, as indicated by her contributions on key regulatory approvals (NORVIRÒ,KALETRAÒ, ZEMPLARÒ, VIEKIRA PAKÒ, ORILISSAÒ, VYLEESIÒ), and has strong leadership skills exemplified in both large and small pharma settings in matrix cross-functional organizations. At AMAG Pharmaceuticals, Laura served as Senior Vice President and Head of Clinical Development and Biostatistics, where she was responsible for four investigational-staged assets and two on-market compounds. Prior to AMAG, she served as vice president of clinical development at Myovant Sciences, where she oversaw clinical development for an infertility
treatment and co-led business development activities to expand the women’s health pipeline. Previously, in her 18-year career at Abbott/AbbVie, she held roles of increasing responsibility, leading clinical development programs across multiple therapeutic areas that spanned all phases of drug development.

Dr. Williams received a Bachelor of Science degree from Mississippi State University, a Doctor of Medicine degree from University of Iowa, and a Master of Public Health degree in Epidemiology from University of Washington, where she also completed a fellowship in Infectious Diseases. She completed her Internal Medicine residency at University of Michigan, where she also served as Chief Resident and Junior Faculty.